Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Dr. Dennis Slamon Discusses the Development of Herceptin

POSTED: Nov. 3, 2008 Share/Bookmark

Herception -- a targeted therapy breast cancer drug developed at UCLA's Jonsson Comprehensive Cancer Center -- saved the life of Louise Cooper, who is still going strong 10 years after receiving a cancer diagnosis.

Last updated: 1/25/2010 11:42:21 AM